Pilot Study of Imatinib (Gleevec) as Treatment for Advanced Thymic Carcinoma.
Phase of Trial: Phase I
Latest Information Update: 19 Jan 2012
At a glance
- Drugs Imatinib (Primary)
- Indications Malignant thymoma
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 19 Jan 2012 Actual patient number (11) added as reported by ClinicalTrials.gov.
- 19 Jan 2012 Actual end date (1 Mar 2011 ) added as reported by ClinicalTrials.gov.